e-learning
resources
London 2016
Sunday, 04.09.2016
Paediatric respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New arguments for double action release active drugs in preparation for vaccination against pneumococcus among children with chronic sites of infection in nasopharynx
Vera Vavilova (Kemerovo, Russian Federation), Vera Vavilova, Alexander Vavilov, Asya Cherkaeva, Irina Nechaeva, Alla Evstratenko
Source:
International Congress 2016 – Paediatric respiratory infections
Session:
Paediatric respiratory infections
Session type:
Thematic Poster
Number:
1270
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vera Vavilova (Kemerovo, Russian Federation), Vera Vavilova, Alexander Vavilov, Asya Cherkaeva, Irina Nechaeva, Alla Evstratenko. New arguments for double action release active drugs in preparation for vaccination against pneumococcus among children with chronic sites of infection in nasopharynx. Eur Respir J 2016; 48: Suppl. 60, 1270
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Do we treat mycoplasma pneumoniae infections differently during an epidemic?
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Current treatments for respiratory infections in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013
Influenza vaccination in chronic asthma patients. Are more severely ill patients more likely to seek vaccination?
Source: Annual Congress 2013 –Viral infections
Year: 2013
Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
The diagnosis of latent tuberculosis infection in children with new immunologic tests
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Management of patients with an inadequate haemophilus influenzae type b antibody response
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Susceptibility to influenza virus infection in asthma biopsies and the effect of topical steroids
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Anti-tuberculosis drug concentrations and treatment outcomes in patients with both tuberculosis and HIV infection
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
Efficacy of vaccination to prevent pneumococcal infection in organized communities
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
BCG vaccination in childhood is not related to pulmonary immunity against
M. tuberculosis
in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014
New treatments for RSV and other viruses, including update on vaccines
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Do school holidays affect adult pneumococcal community acquired pneumonia incidence?
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Should patients with active tuberculosis be routinely screened for chronic viral hepatitis?
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Assessment of BCG immunization effectiveness in children from TB infection sources
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Effects of vaccination on clinical presentation of community acquired pneumonia (CAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Risk of developing active TB in children with latent TB infection
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept